Clinical Impact of MeltDose Technology Extended-Release Tacrolimus (LCPT) in Solid Organ Transplantation: A Systematic Review
Drug Design, Development and Therapy · 2026-06 · Volume 20 · 1-10
DOI: 10.2147/dddt.s613201 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Drug Design, Development and Therapy, 2026-06. Verfasst von Bassem A Almalki. Beteiligte Einrichtung: Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia. Hauptthemen laut MEDLINE: Tacrolimus, Immunosuppressive Agents, Organ Transplantation, Graft Rejection. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice, College of Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
ORCID-Profile: Bassem A Almalki
Zitieren
APA
Almalki, B. A. (2026). Clinical Impact of MeltDose Technology Extended-Release Tacrolimus (LCPT) in Solid Organ Transplantation: A Systematic Review. Drug Design, Development and Therapy, Volume 20, 1-10. https://doi.org/10.2147/dddt.s613201
Vancouver
Almalki BA. Clinical Impact of MeltDose Technology Extended-Release Tacrolimus (LCPT) in Solid Organ Transplantation: A Systematic Review. Drug Design, Development and Therapy. 2026;Volume 20:1-10. doi:10.2147/dddt.s613201
BibTeX
@article{Almalki2026,
author = {Almalki, Bassem A},
title = {Clinical Impact of MeltDose Technology Extended-Release Tacrolimus (LCPT) in Solid Organ Transplantation: A Systematic Review},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--10},
doi = {10.2147/dddt.s613201}
}
EUVIMED